Crossmark

Serum alanine aminotransferase activity and risk factors for cardiovascular disease in a Caucasian population: the Tromsø study

Published Online: 2021-01-13

Published Print: 2021-12

Authors

Bekkelund, Svein Ivar http://orcid.org/0000-0002-8464-7199
License Information

Text and Data Mining valid from 2021-01-13

Version of Record valid from 2021-01-13
More Information

Article History

Received: 23 September 2020

Accepted: 14 December 2020

First Online: 13 January 2021

Ethics approval and consent to participate

: The Tromsø study was approved by the Norwegian Committee for Medical and Health Research Ethics (REC), reference number 121/2006. All participants in The Tromsø Study have given informed written consent.

: Not applicable.

: The author declares that there is no conflict of interest related to the study.

Document is current